Direct IHC describes a polymerized HRP that is conjugated directly onto primary including therapeutic antibodies. This platform is further advanced from our polymer detection systems, resulting in simpler and faster IHC procedures that removes the intermediate steps in standard IHC. We define this new technology as Direct IHC. The corresponding branded Novodiax ihcDirect™ product line offers unique advantages over other IHC products currently in the market.
Our Direct IHC is a revolutionary technology (patent pending) that opens a spectrum of new applications. For more details, see our ihcDirect product list.